医学
肝硬化
肝细胞癌
危险系数
胃肠病学
内科学
丙型肝炎
乙型肝炎
人口
脂肪肝
置信区间
疾病
环境卫生
作者
Mei‐Hsuan Lee,Yi-Ting Chen,Yu-Han Huang,Sheng-Nan Lu,Tsai-Hsuan Yang,Jee‐Fu Huang,Szu‐Ching Yin,Ming-Lun Yeh,Chung-Feng Huang,Chia-Yen Dai,Wan‐Long Chuang,Ming‐Lung Yu,Hwai‐I Yang,Hsuan‐Yu Chen,Chien‐Jen Chen
标识
DOI:10.1016/j.cgh.2024.01.045
摘要
The impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on the development of cirrhosis and hepatocellular carcinoma (HCC) by chronic hepatitis B (CHB) or C infection and antiviral treatment statuses is not well-known.
科研通智能强力驱动
Strongly Powered by AbleSci AI